Aarti Pharmalabs Limited has informed the Exchange about change in Management
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
At the 6th Annual General Meeting held on September 22, 2025, shareholders of Aarti Pharmalabs approved two items. First, Smt. Rupal Vora (DIN: 07096253) was re-appointed as a Non-Executive Independent Director for a second term of 3 years starting October 17, 2025. She is a seasoned legal and tax professional with over 25 years of experience and currently serves on the boards of multiple listed and unlisted companies. Second, M/s. Mehta & Mehta, Practicing Company Secretaries with 25+ years of experience, was appointed as the Secretarial Auditor for a term of 5 consecutive years starting FY 2025-26.
These are routine governance items with no material impact on the stock. The re-appointment of an experienced independent director and the engagement of a well-established secretarial auditor signal continued stability and compliance orientation on the board.